Middle East & Africa Cranial Implants Market
Published On: Aug 2025
Published On: Aug 2025
According to Business Market Insights research, the Middle East & Africa cranial implants market was valued at US$ 80.55 million in 2023 and is expected to reach US$ 129.35 million by 2031, registering a CAGR of 6.1% from 2023 to 2031. Increase in the prevalence of traumatic brain injuries and customized implants are among the critical factors attributed to driving the Middle East & Africa cranial implants market growth.
Traumatic brain injuries (TBIs) constitute one of the significant public health concerns as they interrupt the normal functioning of the brain due to external mechanical force. The common causes of TBIs include falls, motor vehicle accidents, and sports injuries, mainly affecting younger adults and older adults. TBIs vary from mild concussions to severe injuries that result in lifelong cognitive, physical, and emotional disabilities. According to a report published in The Lancet Neurology Commissions in 2022, TBI is one of the leading causes of injury-related death and disability, affecting 55 million people worldwide and costing over US$ 400 billion every year. The demand for effective treatment options, particularly cranial implants, is on the rise due to the increasing number of TBI cases. These implants play a crucial role in treating patients with severe head injuries by safeguarding the brain from further trauma and assisting in the restoration of the skull's protective function. As the prevalence of TBI continues to rise, the demand for cranial implants is expected to surge in the coming years as well.
On the contrary, the risk of implant failure hampers the growth of Middle East & Africa cranial implants market.
By type, the Middle East & Africa cranial implants market is segmented into parietal, frontal, occipital, temporal, and sphenoid. The parietal held 33.3% share of Middle East & Africa cranial implants market share in 2023, amassing US$ 26.84 million. It is projected to garner US$ 44.70 million by 2031 to register 6.6% CAGR during 2023–2031.
In terms of material, the Middle East & Africa cranial implants market is segmented into polymethyl methacrylate, polyether ether ketone, titanium, and others. The polyether ether ketone held 44.4% share of Middle East & Africa cranial implants market share in 2023, amassing US$ 35.79 million. It is projected to garner US$ 57.87 million by 2031 to register 6.2% CAGR during 2023–2031.
Based on end user, the Middle East & Africa cranial implants market is segmented into hospitals, trauma centers, and others. The hospitals held a 59.9% share of Middle East & Africa cranial implants market share in 2023, amassing US$ 48.29 million. It is projected to garner US$ 80.60 million by 2031 to register 6.6% CAGR during 2023–2031.
Based on country, the Middle East & Africa cranial implants market is categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 36.7% share of Middle East & Africa cranial implants market in 2023. It was assessed at US$ 29.58 million in 2023 and is likely to hit US$ 47.08 million by 2031, registering a CAGR of 6.0% during 2023–2031.
Key players operating in the cranial implants market are Stryker Corp, Zimmer Biomet Holdings Inc, Integra LifeSciences Holdings Corp, OsteoMed SA, Anatomics Pty Ltd, Matrix Surgical Holdings LLC, Calavera Surgical, Medtronic Plc, Xilloc Medical BV, Johnson & Johnson, evonos GmbH & Co. KG, B Braun SE, UAB Ortho Baltic, 3D Systems Corp, GPC Medical Ltd, Bioplate Inc, EUROS SAS, Biocomposites Ltd, Medprin Biotech GmbH, Kelyniam Global Inc, MedCAD, KLS Martin Group, and Longeviti Neuro Solutions LLC, among others.
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
